Literature DB >> 29669731

Involvement of Activated Brain Stress Responsive Systems in Excessive and "Relapse" Alcohol Drinking in Rodent Models: Implications for Therapeutics.

Yan Zhou1, Mary Jeanne Kreek2.   

Abstract

Addictive diseases, including addiction to alcohol, pose massive public health costs. Addiction is a chronic relapsing disease caused by both the direct effects induced by drugs and persistent neuroadaptations at the molecular, cellular, and behavioral levels. These drug-type specific neuroadaptations are brought on largely by the reinforcing effects of drugs on the central nervous system and environmental stressors. Results from animal experiments have demonstrated important interactions between alcohol and stress-responsive systems. Addiction to specific drugs such as alcohol, psychostimulants, and opioids shares some common direct or downstream effects on the brain's stress-responsive systems, including arginine vasopressin and its V1b receptors, dynorphin and the κ-opioid receptors, pro-opiomelanocortin/β-endorphin and the μ-opioid receptors, and the endocannabinoids. Further study of these systems through laboratory-based and translational research could lead to the discovery of novel treatment targets and the early optimization of interventions (for example, combination) for the pharmacologic therapy of alcoholism.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Year:  2018        PMID: 29669731      PMCID: PMC5988024          DOI: 10.1124/jpet.117.245621

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  221 in total

1.  Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.

Authors:  Yan Zhou; Rachel Saylor Crowley; Konrad Ben; Thomas E Prisinzano; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2017-03-02       Impact factor: 3.252

2.  Involvement of Endocannabinoids in Alcohol "Binge" Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists.

Authors:  Yan Zhou; Ted Huang; Francis Lee; Mary Jeanne Kreek
Journal:  Alcohol Clin Exp Res       Date:  2016-02-09       Impact factor: 3.455

3.  Loss of vasopressin-immunoreactive neurons in alcoholics is dose-related and time-dependent.

Authors:  A J Harding; G M Halliday; J L Ng; C G Harper; J J Kril
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

4.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

5.  Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats.

Authors:  Yan Zhou; Francesco Leri; Stephanie L Grella; Jane V Aldrich; Mary Jeanne Kreek
Journal:  Synapse       Date:  2013-02-26       Impact factor: 2.562

6.  Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone.

Authors:  A Kuzmin; J Sandin; L Terenius; S O Ogren
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

7.  Hypothalamic-pituitary-adrenal system adaptation to detoxification in alcohol-dependent patients is affected by family history of alcoholism.

Authors:  Ulrich Zimmermann; Wolfgang Hundt; Konstanze Spring; Andreas Grabner; Florian Holsboer
Journal:  Biol Psychiatry       Date:  2003-01-01       Impact factor: 13.382

Review 8.  Neuroscience of opiates for addiction medicine: From stress-responsive systems to behavior.

Authors:  Yan Zhou; Francesco Leri
Journal:  Prog Brain Res       Date:  2015-10-17       Impact factor: 2.453

9.  Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids.

Authors:  Wouter Goutier; Margreet Kloeze; Andrew C McCreary
Journal:  Addict Biol       Date:  2014-10-13       Impact factor: 4.280

10.  Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice.

Authors:  Balapal S Basavarajappa; Nagaraja N Nagre; Shan Xie; Shivakumar Subbanna
Journal:  Hippocampus       Date:  2014-03-28       Impact factor: 3.899

View more
  10 in total

Review 1.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

2.  mTORC1 pathway is involved in the kappa opioid receptor activation-induced increase in excessive alcohol drinking in mice.

Authors:  Yan Zhou; Yupu Liang; Mary Jeanne Kreek
Journal:  Pharmacol Biochem Behav       Date:  2020-05-26       Impact factor: 3.533

Review 3.  Translational approach to understanding momentary factors associated with alcohol consumption.

Authors:  Valentina Vengeliene; Jerome Clifford Foo; Jinhyuk Kim
Journal:  Br J Pharmacol       Date:  2020-07-30       Impact factor: 8.739

4.  Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2019-08-27       Impact factor: 3.252

Review 5.  Behavioral, neurobiological, and neurochemical mechanisms of ethanol self-administration: A translational review.

Authors:  Ashley A Vena; Shannon L Zandy; Roberto U Cofresí; Rueben A Gonzales
Journal:  Pharmacol Ther       Date:  2020-05-11       Impact factor: 12.310

6.  Combination of Clinically Utilized Kappa-Opioid Receptor Agonist Nalfurafine With Low-Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  Alcohol Clin Exp Res       Date:  2019-05-02       Impact factor: 3.455

7.  Nuclear transcriptional changes in hypothalamus of Pomc enhancer knockout mice after excessive alcohol drinking.

Authors:  Yan Zhou; Yupu Liang; Malcolm J Low; Mary J Kreek
Journal:  Genes Brain Behav       Date:  2019-08-08       Impact factor: 3.449

8.  Blockade of alcohol excessive and "relapse" drinking in male mice by pharmacological cryptochrome (CRY) activation.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2021-01-08       Impact factor: 4.530

9.  Endocannabinoids and Fear-Related Behavior in Mice Selectively Bred for High or Low Alcohol Preference.

Authors:  Aaron M Kirchhoff; Eric L Barker; Julia A Chester
Journal:  Brain Sci       Date:  2019-09-26

10.  Aticaprant (Clinically Developed Kappa-Opioid Receptor Antagonist) Combined With Naltrexone Prevents Alcohol "Relapse" Drinking.

Authors:  Y Zhou; D C Zhou; M J Kreek
Journal:  J Pharm Pharmacol (Los Angel)       Date:  2022-05-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.